BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19121184)

  • 1. The characterization and impact of microparticles on haemostasis within fresh-frozen plasma.
    Lawrie AS; Harrison P; Cardigan RA; Mackie IJ
    Vox Sang; 2008 Oct; 95(3):197-204. PubMed ID: 19121184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-analytical and analytical issues in the analysis of blood microparticles.
    Yuana Y; Bertina RM; Osanto S
    Thromb Haemost; 2011 Mar; 105(3):396-408. PubMed ID: 21174005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
    Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
    Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A heparin-based method for flow cytometric analysis of microparticles directly from platelet-poor plasma in calcium containing buffer.
    Iversen LV; Ostergaard O; Nielsen CT; Jacobsen S; Heegaard NH
    J Immunol Methods; 2013 Feb; 388(1-2):49-59. PubMed ID: 23246793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations.
    Sparrow RL; Chan KS
    J Proteomics; 2012 Dec; 76 Spec No.(0 0):211-9. PubMed ID: 22813882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donor age, donor sex, blood-component processing, and storage on cell-derived microparticle concentrations in routine blood-component preparation.
    Noulsri E; Palasuwan A
    Transfus Apher Sci; 2018 Aug; 57(4):587-592. PubMed ID: 30082165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of cell membrane microparticles.
    Gelderman MP; Simak J
    Methods Mol Biol; 2008; 484():79-93. PubMed ID: 18592174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microparticle sizing by dynamic light scattering in fresh-frozen plasma.
    Lawrie AS; Albanyan A; Cardigan RA; Mackie IJ; Harrison P
    Vox Sang; 2009 Apr; 96(3):206-12. PubMed ID: 19175566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperatively salvaged red blood cells contain nearly no functionally active platelets, but exhibit formation of microparticles: results of a pilot study in orthopedic patients.
    Oswald E; Streif W; Hermann M; Hengster P; Mittermayr M; Innerhofer P
    Transfusion; 2010 Feb; 50(2):400-6. PubMed ID: 19804574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and comparison of coagulation factor activity in fresh-frozen plasma and 24-hour plasma at thaw and after 120 hours of 1 to 6°C storage.
    Scott E; Puca K; Heraly J; Gottschall J; Friedman K
    Transfusion; 2009 Aug; 49(8):1584-91. PubMed ID: 19413730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticle formation after exposure of blood to activated endothelium under flow.
    Macey MG; Wolf SI; Lawson C
    Cytometry A; 2010 Aug; 77(8):761-8. PubMed ID: 20653016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
    Holland LL; Brooks JP
    Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric analysis of microparticles.
    van der Heyde HC; Gramaglia I; Combes V; George TC; Grau GE
    Methods Mol Biol; 2011; 699():337-54. PubMed ID: 21116991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of procoagulant activity of microparticles in plasma: feasibility of new functional assays.
    Marco A; Brocal C; Marco P
    Thromb Res; 2014 Dec; 134(6):1363-4. PubMed ID: 25282540
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children.
    Stanworth SJ; Grant-Casey J; Lowe D; Laffan M; New H; Murphy MF; Allard S
    Transfusion; 2011 Jan; 51(1):62-70. PubMed ID: 20804532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications.
    Salomon O; Katz BZ; Dardik R; Livnat T; Steinberg DM; Achiron R; Seligsohn U
    Fertil Steril; 2009 Aug; 92(2):682-7. PubMed ID: 18692836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
    Connor DE; Exner T; Ma DD; Joseph JE
    Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanofiltration to remove microparticles and decrease the thrombogenicity of plasma: in vitro feasibility assessment.
    Chou ML; Lin LT; Devos D; Burnouf T
    Transfusion; 2015 Oct; 55(10):2433-44. PubMed ID: 25988671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dynamics of clot formation in fresh-frozen plasma.
    Lawrie AS; Cardigan RA; Williamson LM; Machin SJ; Mackie IJ
    Vox Sang; 2008 May; 94(4):306-14. PubMed ID: 18266780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From plasma transfusion to individualized, goal-directed coagulation factor administration.
    Spahn DR
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S16-9. PubMed ID: 23910532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.